Mapping spatial relationships between residues in the ligand-binding domain of the 5-Ht3 receptor using a molecular ruler

Biophysical Journal

Volumn 98, Issue 9, 2010, Pages 1847-1855

  Nyce, Heather L ^a   Stober, Spencer T ^b   Abrams, Cameron F ^b   White, Michael M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Drexel University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952283794     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.01.034     Document Type: Article

References (70)

1. Connolly, C. N., and K. A. Waffard. 2004. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function, Biochem. Soc. Trans. 32:529-534.
2. Lester, H. A., M. I. Dibas, D. A. Dougherty. 2004. Cys-loop receptors: new twists and turns. Trends Neurosci. 27:329-336.
3. Reeves, D. C., and S. C. Lummis. 2002. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol. Membr. Biol. 19:11-26.
4. 3 receptor, a serotonin-gated ion channel. Science. 254:432-437.
5. Hussy, N., W. Lukas, and K. A. Jones. 1994. Functional properties of a cloned 5 -hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J. Physiol. 481:311-323.
6. 3B subunit is a major determinant of serotonin-receptor function. Nature. 397:359-363.
7. Jensen, A. A., P. A. Davies, K. Krzywkowski. 2008. 3B but which 3B? And that's just one of the questions: the heterogeneity of human 5-HT3 receptors. Trends Pharmacol. Sci. 29:437-444.
8. 3A/3B receptors. Neuropharmacology. 41:282-284.
9. (3) receptors in rodents. J. Neurochem. 75:240-247.
10. (3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine. Bioorg. Med. Chem. 17:5796-5805.
11. 3A receptor model. Biochemistry. 45:1099-1105.
12. 3 receptor F-loop. J. Biol. Chem. 281:16576-16582.
13. Thompson, A. J., K. L. Price, .., S. C. Lummis. 2005. Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding. J. Biol. Chem. 280:20476-20482.
14. Thompson, A. J., M. Lochner, and S. C. R. Lummis. 2008. Loop B is a major structural component of the 5-HT3 receptor. Biophys. J. 95:5728-5736.
15. (3) receptor onto d-tubocurarine structure. Mol. Pharmacol. 70:571-578.
16. 16. Yan, D., and M. M. White. 2005. Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor. Mol. Pharmacol. 68:365-371. (Pubitemid 41058300)
17. 17. Brejc, K., W. J. van Dijk, T. K. Sixma. 2001. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 411:269-276. (Pubitemid 32467026)
18. Horovitz, A. 1996. Double-mutant cycles: a powerful tool for analyzing protein structure and function. Fold. Des. 1:R121-R126.
19. Jenkinson, D. H. 1960. The antagonism between tubocurarine and substances which depolarize the motor end-plate. J. Physiol. 152: 309-324.
20. Peters, J. A., H. M. Malone, and J. J. Lambert. 1990. Antagonism of 5-HT3 receptor mediated currents in murine N1E-11.5 neuroblastoma cells by (+)-tubocurarine. Neurosci. Lett. 110:107-112.
21. 3A receptor subunits. Mol. Pharmacol. 55:1037-1043.
22. 22. Zhang, R., X. Wen, T. Machu. 2006. The role of loop F residues in determining differential d-tubocurarine potencies in mouse and human 5-hydroxytryptamine 3A receptors. Biochemistry. 46:1194-1204. (Pubitemid 46208468)
23. 23. Papineni, R. V., and S. E. Pedersen. 1997. Interaction of d-tubocurarine analogs with the mouse nicotinic acetylcholine receptor. Ligand orientation at the binding site. J. Biol, Chem. 272:24891-24898. (Pubitemid 27415663)
24. Pedersen, S. E., and R. V. Papineni. 1995. Interaction of d-tubocurarine analogs with the Torpedo nicotinic acetylcholine receptor. Methylation and stereoisomerization affect site-selective competitive binding and binding to the noncompetitive site. J. Biol. Chem. 270:31141-31150.
25. 3 receptor. Neuropharmacology. 37: 251-257.
26. 3 receptor A subunit. Eur. J. Pharmacol. 245:187-192.
27. 3 receptor. J. Biol. Chem. 274:5537-5541.
28. i and the concentration, of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108.
29. Ku, H. 1966. Notes on the use of propagation of error formulas. J. Res. Natl. Bur. Stand., C Eng. Instrum. 70C:263-273.
30. 3 receptor label both native and recombinant receptors. Brain Res. Mol. Brain Res. 67:221-230.
31. Fiser, A., R. K. Do, and A. Sali. 2000. Modeling of loops in protein structures. Protein Sci. 9:1753-1773.
32. Sali, A., and T. L. Blundell. 1993. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779-815.
33. Hansen, S. B., G. Sulzenbacher, Y. Bourne. 2005. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal, distinctive binding interfaces and conformations. EMBO J. 24:3635-3646.
34. Sippl, M. J. 1993. Recognition, of errors in three-dimensional structures of proteins. Proteins. 17:355-362.
35. Morris, G. M., R. Huey, A. J. Olson. 2009. AutoDock4 and AutoDockTools4: automated docking with, selective receptor flexibility. J. Comput. Chem. 30:2785-2791.
36. Osterberg, F., G. Morris, D. Goodsell. 2002. Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins. 46:34-40.
37. Hornak, V., R. Abel, C. Simmerling. 2006. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 65:712-725.
38. Wang, J., R. M. Wolf, D. A. Case. 2004. Development and testing of a general Amber force field. J. Comput. Chem. 25:1157-1174.
39. Jakalian, A., B. Bush, C. Bayly. 2000. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. J. Comput. Chem. 21:132-146.
40. 40. Jakalian, A., D. B. Jack, and C. I. Bayly. 2002. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 23:1623-1641. (Pubitemid 35330860)
41. Jorgensen, W., J. Chandrasekhar, M. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
42. Phillips, J. C., R. Braun, K. Schulten. 2005. Scalable molecular dynamics with NAMD. J. Comput. Chem. 26:1781-1802.
43. 3 receptor: the role of glutamate residues 97, 224, and 235. J. Biol. Chem. 278:22709-22716.
44. + channel pore through mutant cycles with a peptide inhibitor. Science. 268:307-310.
45. + channel selectivity filter by mutant cycle-based structure analysis. Neuron. 16:131-139.
46. 46. Malany, S., H. Osaka, P. Taylor. 2000. Orientation of α-neurotoxin at the subunit interfaces of the nicotinic acetylcholine receptor. Biochemistry. 39:15388-15398. (Pubitemid 32002765)
47. Willcockson, I, U., A. Hong, S. E. Pedersen. 2002. Orientation of d-tubocurarine in the muscle nicotinic acetylcholine receptor-binding site. J. Biol. Chem. 277:42249-42258.
48. Schreiber, G., and A. R. Fersht. 1995. Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. J. Mol. Biol. 248:478-486.
49. 3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology. 36:637-647.
50. Sullivan, N. L., A. J. Thompson, S. C. Lummis. 2006. Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT3 receptor. Mol, Membr. Biol. 23:442-451.
51. 3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide. Biochemistry. 44:9140-9149.
52. Venkataraman, P., S. P. Venkatachalan, M. K. Schulte. 2002. Identification of critical residues in loop E in the 5-HT3ASR binding site. BMC Biochem. 3:15.
53. Sullivan, D., D. C. Chiara, and J. B. Cohen, 2002. Mapping the agonist binding site of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis: antagonist footprint and secondary structure prediction. Mol, Pharmacol. 61:463-472.
54. (A) receptor. J. Neurosci. 24:2733-2741.
55. Zamyatnin, A. A. 1984. Amino acid, peptide, and protein volume in. solution. Annu. Rev. Biophys. Bioeng. 13:145-165.
56. 3 receptor. Biochemistry. 47:6370-6377.
57. Codding, P., and M. James. 1973. The crystal and molecular structure of a potent neuromuscular blocking agent: d-tubocurarine dichloride pentahydrate. Acta Crystallogr. B. 29:935-942.
58. Reynolds, C., and R., Palmer. 1976. The crystal structure, absolute configuration and stereochemistry of (+)-tubocurarine dibromide meth- anol solvate: a potent neuromuscular blocking agent. Acta Crystallogr. B. 32:1431-1439.
59. Bondi, A. 1964. van der Waals volumes and radii. J. Phys. Chem. 68:441-451.
60. Wallner, B., and A. Elofsson. 2005. All are not equal: a benchmark of different homology modeling programs. Protein Sci. 14:1315-1327.
61. Hibbs, R. E., Z. Radie, D. A. Johnson. 2006. Influence of agonists and antagonists on the segmental motion of residues near the agonist binding pocket of the acetylcholine-binding protein. J. Biol, Chem. 28.1:39708-39718.
62. Hibbs, R. E., T. T. Talley, and P. Taylor. 2004. Acrylodan-conjugated cysteine side chains reveal conformational, state and ligand site locations of the acetylcholine-binding protein. J. Biol. Chem. 279:28483-28491.
63. Henchman, R. H., H.-L. Wang, J. A. McCammon, 2005. Ligandinduced conformational change in the α7 nicotinic receptor ligand binding domain. Biophys. J. 88:2564-2576.
64. Henchman, R. H., H.-L. Wang, J. A. McCammon. 2003. Asymmetric structural motions of the homomeric α7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation. Biophys. J. 85:3007-3018.
65. Law, R. J., R. H. Henchman, and J. A. McCammon. 2005. A gating mechanism proposed from a simulation of a human al nicotinic acetylcholine receptor. Proc. Natl, Acad. Sci. USA. 102:6813-6818.
66. Speranskiy, K., M. Cascio, and M. Kurnikova. 2007. Homology modeling and molecular dynamics simulations of the glycine receptor ligand binding domain. Proteins. 67:950-960.
67. + channel: a computational approach based on experimental, distance restraints extracted from thermodynamic mutant cycles. Biophys. J. 83:2595-2609.
68. Cohen, L., I. Karbat, M. Gurevitz. 2005. Common features in the functional surface of scorpion β-toxins and elements that confer specificity for insect and mammalian voltage-gated sodium channels. J. Biol. Chem. 280:5045-5053.
69. Nielsen, K. J., T. Schroeder, and R. Lewis. 2000. Structure-activity relationships of w-conotoxins at N-type voltage-sensitive calcium channels. J. Mol. Recognit. 13:55-70.
70. Nicke, A., S. Wonnacott, and R. J. Lewis. 2004. a-Conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. Eur. J. Biochem. 271:2305-2319.